PL2047855T3 - Farmaceutyczny skład antyblastyczny, antybakteryjny i wirusobójczy (odmiany) - Google Patents

Farmaceutyczny skład antyblastyczny, antybakteryjny i wirusobójczy (odmiany)

Info

Publication number
PL2047855T3
PL2047855T3 PL07794063T PL07794063T PL2047855T3 PL 2047855 T3 PL2047855 T3 PL 2047855T3 PL 07794063 T PL07794063 T PL 07794063T PL 07794063 T PL07794063 T PL 07794063T PL 2047855 T3 PL2047855 T3 PL 2047855T3
Authority
PL
Poland
Prior art keywords
tumoral
antibacterial
acid
variants
pharmaceutical composition
Prior art date
Application number
PL07794063T
Other languages
English (en)
Inventor
Vladimir Mikhaylovich Plotnikov
Original Assignee
Badulin Nikolay Aleksandrovich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Badulin Nikolay Aleksandrovich filed Critical Badulin Nikolay Aleksandrovich
Publication of PL2047855T3 publication Critical patent/PL2047855T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
PL07794063T 2006-07-12 2007-06-21 Farmaceutyczny skład antyblastyczny, antybakteryjny i wirusobójczy (odmiany) PL2047855T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2006125085/15A RU2319491C1 (ru) 2006-07-12 2006-07-12 Противоопухолевая, антибактериальная и антивирусная фармацевтическая композиция (ее варианты)
EP07794063A EP2047855B1 (de) 2006-07-12 2007-06-21 Antitumorale, antibakterielle und antivirale pharmazeutische zusammensetzung (varianten)
PCT/RU2007/000341 WO2008007999A1 (fr) 2006-07-12 2007-06-21 Composition antitumorale, antibactérienne et antivirale (et variantes)

Publications (1)

Publication Number Publication Date
PL2047855T3 true PL2047855T3 (pl) 2011-03-31

Family

ID=38923476

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07794063T PL2047855T3 (pl) 2006-07-12 2007-06-21 Farmaceutyczny skład antyblastyczny, antybakteryjny i wirusobójczy (odmiany)

Country Status (11)

Country Link
US (1) US20090136590A1 (pl)
EP (1) EP2047855B1 (pl)
CN (1) CN101516384B (pl)
AT (1) ATE478673T1 (pl)
DE (1) DE502007004869D1 (pl)
EA (1) EA014603B1 (pl)
PL (1) PL2047855T3 (pl)
RU (1) RU2319491C1 (pl)
SI (1) SI2047855T1 (pl)
UA (1) UA90965C2 (pl)
WO (1) WO2008007999A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895610B1 (en) 2007-05-18 2014-11-25 Heldi Kay Platinum (IV) compounds targeting zinc finger domains
RU2468447C1 (ru) * 2011-06-27 2012-11-27 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России) Способ индукции цитотоксического действия на опухолевые клетки
RU2549495C1 (ru) * 2014-06-27 2015-04-27 Общество с ограниченной ответственностью "НаноФарм-про" Способ получения средства на основе гексаметилентетрамина и наноселена, оказывающего стимулирующее действие на клетки организма
RU2593587C1 (ru) * 2015-03-30 2016-08-10 Евгений Владимирович Плотников Антиоксидантная композиция(варианты)
RU2608130C1 (ru) * 2016-02-02 2017-01-13 Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский политехнический университет" Способ и фармацевтическая композиция для лечения вирусного лейкоза крупного рогатого скота

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946954A (en) 1989-01-17 1990-08-07 Georgetown University Platinum pharmaceutical agents
RU2114858C1 (ru) 1995-06-26 1998-07-10 Владимир Михайлович Плотников Производные дихлорида цис-диамминдиимидазолил платины, проявляющие антипролиферативную активность, и способ их получения
RU2094048C1 (ru) 1995-08-18 1997-10-27 Владимир Михайлович Плотников Цитостатический и антивирусный состав
RU2181050C2 (ru) 1999-05-21 2002-04-10 Плотников Владимир Михайлович Противоопухолевая и антибактериальная композиция
WO2004110361A2 (en) * 2003-05-20 2004-12-23 Hong Ji Zhong Anticancer compositions comprising methenamine
RU2242977C1 (ru) * 2003-09-30 2004-12-27 Плотников Евгений Владимирович Антивирусная и бактерицидная композиция
JP4912148B2 (ja) * 2004-08-03 2012-04-11 中外製薬株式会社 新規イミダゾリジン誘導体

Also Published As

Publication number Publication date
CN101516384A (zh) 2009-08-26
SI2047855T1 (sl) 2011-02-28
CN101516384B (zh) 2012-07-04
EA014603B1 (ru) 2010-12-30
RU2319491C1 (ru) 2008-03-20
DE502007004869D1 (de) 2010-10-07
EP2047855B1 (de) 2010-08-25
US20090136590A1 (en) 2009-05-28
UA90965C2 (ru) 2010-06-10
WO2008007999A1 (fr) 2008-01-17
EA200900077A1 (ru) 2009-04-28
EP2047855A1 (de) 2009-04-15
ATE478673T1 (de) 2010-09-15
EP2047855A4 (de) 2009-11-11

Similar Documents

Publication Publication Date Title
HRP20200777T1 (hr) Formulacije koje sadrže triazinone i željezo
SG157406A1 (en) Oral medicament for the modified release of at least one active principle, in multi-microcapsule form
EA200600696A1 (ru) Фармацевтические композиции для предотвращения передозировки или неправильного употребления лекарственных средств
SI2529622T1 (en) Bruton tyrosine kinase inhibitors
HK1104530A1 (en) Medicaments with hm74a receptor activity
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
UA96965C2 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 2,3-ДИГИДРОИМИДАЗО[1,2-с]ХИНАЗОЛИНА, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ НАРУШЕНИЙ И БОЛЕЗНЕЙ, СВЯЗАННЫХ С АНГИОГЕНЕЗОМ
PE20140854A1 (es) Formas de dosificacion farmaceutica
IL197393A (en) History of pyridine-4-ram, containing and using pharmaceutical preparations for the preparation of drugs for the treatment of immune-related diseases
IL179718A0 (en) Pharmaceutical composition containing irbesartan
MX2010007523A (es) Nuevos derivados de pirazolo[3,4-d]pirimidina como farmacos anticancer.
MXPA05013637A (es) Inhibidores gsk-3 y usos de los mismos.
WO2007012019A3 (en) Medicaments containing famotidine and ibuprofen and administration of same
EP2047855A4 (de) Antitumorale, antibakterielle und antivirale pharmazeutische zusammensetzung (varianten)
UA90893C2 (ru) Пероральная дозированная форма производных гемцитабина
MX2009008084A (es) Derivados de 5,6,7,8-tetrahidropteridina como inhibidores de hsp90.
PT2459153E (pt) Composição farmacêutica ou cosmética ou dietética tendo o efeito de favorecer a pigmentação capilar
CL2009001267A1 (es) Compuestos derivados de triciclos nitrogenados, con actividad antibacteriana; procedimiento de preparacion; composicion farmceutica que los comprende; para el tratamiento de la tuberculosis.
MX2008011020A (es) Compuestos de receptor sigma.
WO2009088673A3 (en) Pharmaceutical composition
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
MX2009005912A (es) Derivados de etilamina-fenilo heterociclilo sustituidos, su preparacion y uso como medicamentos.
WO2004033484A3 (en) Use of stable glutamine derivatives to improve drug absorption
BRPI0907203A2 (pt) Forma galênica para a administração de triptanos via transmucosa oral
MD3120F1 (en) Method of influenza prophylaxis